Jeffrey Bednarski

Medicine & Life Sciences

1. 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione 48%
2. Alemtuzumab 36%
3. Antigen Receptors 54%
4. Apoptosis 21%
5. Ataxia Telangiectasia 60%
6. B-Lymphocytes 89%
7. B-Lymphoid Precursor Cells 73%
8. Benzodiazepines 40%
9. Bone Marrow Failure Disorders 19%
10. Bz-423 65%
11. C2 Domains 19%
12. Cell Transplantation 41%
13. Chronic Granulomatous Disease 35%
14. DNA Breaks 37%
15. DNA Damage 84%
16. Double-Stranded DNA Breaks 100%
17. Ehrlichiosis 19%
18. fludarabine 20%
19. G1 Phase 25%
20. Genes 36%
21. Germinal Center 23%
22. Hematopoietic Stem Cell Transplantation 23%
23. Hematopoietic Stem Cells 27%
24. Hemophagocytic Lymphohistiocytosis 34%
25. Immune Reconstitution 47%
26. Immunoglobulin Light Chain Genes 27%
27. Infections 32%
28. Interleukin-7 32%
29. Laurates 22%
30. Lymphocytes 54%
31. Lymphopoiesis 21%
32. Mutation 20%
33. Neonatal Screening 24%
34. Pediatrics 44%
35. Phosphatidylinositol 4,5-Diphosphate 20%
36. Phosphotransferases 22%
37. Polynucleotide 5'-Hydroxyl-Kinase 20%
38. Pre-B Cell Receptors 22%
39. Primary Immunodeficiency Diseases 39%
40. Severe Combined Immunodeficiency 84%
41. T-Lymphocytes 26%
42. Tetraspanins 19%
43. Thiotepa 19%
44. Tissue Donors 29%
45. Toll-Like Receptor 8 21%
46. Toxoplasma 29%
47. Transcription Factors 24%
48. Transplantation Conditioning 21%
49. Transplants 53%
50. V(D)J Recombination 38%